Diamonds and Dogs

9/29/15

After two straight down days for the healthcare/ biotechs, the sectors are bouncing back today. Cantel (CMN) is the diamond today up 8% following better than expected earnings. The medical equipment maker easily beat estimates while revenue grew 15%. When this correction is over, the biotech and healthcare sectors should outperform once again.

Most biotechs are bouncing back except for today's dog, Galapagos (GLPG). The stock is down 15% today and 30% in the last three days after partner, AbbVie (ABBV) decided not to license its arthritis drug and focus on its own drug. Evercore. The biotech sector is a lot of hits and misses. The last couple years its felt like all the biotechs were a hit, but recently the sector has reminded us that not all biotechs can go up.

Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.